Cost Effectiveness of Mohs Micrographic Surgery Robert S. Stern  Journal of Investigative Dermatology  Volume 133, Issue 5, Pages 1129-1131 (May 2013) DOI: 10.1038/jid.2012.473 Copyright © 2013 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 1 Percent of all nonmelanoma skin cancers treated with Mohs micrographic surgery (MMS) (2009) by state and body site. x Axis: face, scalp, hands, feet, and genitalia (face and other sites). y Axis: trunk, arms, and legs (trunk and extremities). Each data point represents results for a state. The line shows the relationship between the percentage of patients treated with MMS on face, scalp, hands, feet, and genitalia versus other body sites (least squares plot). Data points for selected states are identified by color. The number of Mohs College members per million white population is provided in parenthesis (utilization data from Donaldson and Coldiron (2012). Yellow: New Mexico (2.9); red: Arkansas (3.2); purple: New York (6.6); blue: Nevada (2.8). Journal of Investigative Dermatology 2013 133, 1129-1131DOI: (10.1038/jid.2012.473) Copyright © 2013 The Society for Investigative Dermatology, Inc Terms and Conditions

Journal of Investigative Dermatology 2013 133, 1129-1131DOI: (10 Journal of Investigative Dermatology 2013 133, 1129-1131DOI: (10.1038/jid.2012.473) Copyright © 2013 The Society for Investigative Dermatology, Inc Terms and Conditions